{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:17:21Z","timestamp":1793315841785,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["12,13"],"award-info":[{"award-number":["12,13"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.humpath.2024.105703","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T19:13:09Z","timestamp":1733771589000},"page":"105703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Burkitt lymphoma"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1780-5959","authenticated-orcid":false,"given":"Hong","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.humpath.2024.105703_bib1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.humpath.2024.105703_bib2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2141.2011.09013.x","article-title":"Epidemiology: clues to the pathogenesis of Burkitt lymphoma","volume":"156","author":"Magrath","year":"2012","journal-title":"Br J Haematol"},{"issue":"197","key":"10.1016\/j.humpath.2024.105703_bib3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","article-title":"A sarcoma involving the jaws in African children","volume":"46","author":"Burkitt","year":"1958","journal-title":"Br J Surg"},{"key":"10.1016\/j.humpath.2024.105703_bib4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-3476(60)80369-1","article-title":"Malignant tumors in African children. With special reference to malignant lymphoma","volume":"56","author":"O'Conor","year":"1960","journal-title":"J Pediatr"},{"key":"10.1016\/j.humpath.2024.105703_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/1097-0142(196103\/04)14:2<258::AID-CNCR2820140206>3.0.CO;2-7","article-title":"Malignant lymphoma in African children. I. A clinical syndrome","volume":"14","author":"Burkitt","year":"1961","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2024.105703_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/1097-0142(196103\/04)14:2<270::AID-CNCR2820140207>3.0.CO;2-Q","article-title":"Malignant lymphoma in African children. II. A pathological entity","volume":"14","author":"O'Conor","year":"1961","journal-title":"Cancer"},{"issue":"3792","key":"10.1016\/j.humpath.2024.105703_bib7","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.157.3792.1064","article-title":"Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells","volume":"157","author":"Henle","year":"1967","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.humpath.2024.105703_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ijc.2910010510","article-title":"Burkitt's tumour in England. A comparison with childhood lymphosarcoma","volume":"1","author":"Wright","year":"1966","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2024.105703_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/1097-0142(196504)18:4<411::AID-CNCR2820180403>3.0.CO;2-5","article-title":"Childhood lymphoma resembling \"burkitt tumor\" in the United States","volume":"18","author":"O'Conor","year":"1965","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2024.105703_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/1097-0142(196504)18:4<418::AID-CNCR2820180404>3.0.CO;2-I","article-title":"Childhood lymphosarcoma in ST. LOUIS, Missouri, clinically and histologically resembling BURKITT'S tumor","volume":"18","author":"Dorfman","year":"1965","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.humpath.2024.105703_bib11","first-page":"601","volume":"40","year":"1969","journal-title":"Bull World Health Organ"},{"issue":"5349","key":"10.1016\/j.humpath.2024.105703_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/237033a0","article-title":"Marker band in one chromosome 14 from Burkitt lymphomas","volume":"237","author":"Manolov","year":"1972","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.humpath.2024.105703_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ijc.2910170108","article-title":"Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas","volume":"17","author":"Zech","year":"1976","journal-title":"Int J Cancer"},{"issue":"24","key":"10.1016\/j.humpath.2024.105703_bib14","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.humpath.2024.105703_bib15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","article-title":"The World Health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the clinical advisory committee meeting, airlie house, Virginia, november, 1997","volume":"10","author":"Harris","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2024.105703_bib16","series-title":"Ioachim's lymph node pathology","first-page":"580","article-title":"Burkitt lymphoma","author":"Medeiros","year":"2021"},{"issue":"3","key":"10.1016\/j.humpath.2024.105703_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-3016.1990.tb00654.x","article-title":"International variations in the incidence of childhood lymphomas","volume":"4","author":"Stiller","year":"1990","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105703_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.2910420408","article-title":"The international incidence of childhood cancer","volume":"42","author":"Parkin","year":"1988","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.humpath.2024.105703_bib19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/1097-0142(19820301)49:5<1016::AID-CNCR2820490527>3.0.CO;2-H","article-title":"The American Burkitt's Lymphoma Registry: eight years' experience","volume":"49","author":"Levine","year":"1982","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.humpath.2024.105703_bib20","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s00277-018-3473-8","article-title":"Posttransplant monomorphic Burkitt's lymphoma: clinical characteristics and outcome of a multicenter series","volume":"97","author":"Bobillo","year":"2018","journal-title":"Ann Hematol"},{"issue":"25","key":"10.1016\/j.humpath.2024.105703_bib21","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1182\/blood-2010-03-275917","article-title":"AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and\/or biology?","volume":"116","author":"Guech-Ongey","year":"2010","journal-title":"Blood"},{"issue":"8299","key":"10.1016\/j.humpath.2024.105703_bib22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(82)92740-4","article-title":"Outbreak of Burkitt's-like lymphoma in homosexual men","volume":"2","author":"Ziegler","year":"1982","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.humpath.2024.105703_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1541-7786.MCR-16-0305","article-title":"Comprehensive transcriptome and mutational profiling of endemic Burkitt lymphoma reveals EBV type-specific differences","volume":"15","author":"Kaymaz","year":"2017","journal-title":"Mol Cancer Res"},{"issue":"12","key":"10.1016\/j.humpath.2024.105703_bib24","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105703_bib25","doi-asserted-by":"crossref","DOI":"10.21037\/aol-21-18","article-title":"Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants","volume":"5","author":"Rochford","year":"2021","journal-title":"Ann Lymphoma"},{"issue":"3","key":"10.1016\/j.humpath.2024.105703_bib26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/bjh.17922","article-title":"Epstein-Barr virus positivity as a defining pathogenetic feature of Burkitt lymphoma subtypes","volume":"196","author":"Leoncini","year":"2022","journal-title":"Br J Haematol"},{"issue":"7335","key":"10.1016\/j.humpath.2024.105703_bib27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from BURKITT'S lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.humpath.2024.105703_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.humpath.2024.105703_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-022-00404-3","article-title":"Burkitt lymphoma","volume":"8","author":"L\u00f3pez","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.humpath.2024.105703_bib30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2024.105703_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.20.090501.112049","article-title":"Molecular mechanism of class switch recombination: linkage with somatic hypermutation","volume":"20","author":"Honjo","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"21","key":"10.1016\/j.humpath.2024.105703_bib32","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2018-03-842088","article-title":"IG-MYC (+) neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas","volume":"132","author":"Wagener","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2024.105703_bib33","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-019-08578-3","article-title":"Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma","volume":"10","author":"L\u00f3pez","year":"2019","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.humpath.2024.105703_bib34","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.3324\/haematol.2018.208140","article-title":"Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of \"MYC-negative\" Burkitt lymphoma","volume":"105","author":"Wagener","year":"2020","journal-title":"Haematologica"},{"issue":"23","key":"10.1016\/j.humpath.2024.105703_bib35","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.humpath.2024.105703_bib36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/path.2410","article-title":"MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation","volume":"216","author":"Leucci","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2024.105703_bib37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1186\/s12885-015-1661-7","article-title":"Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation","volume":"15","author":"De Falco","year":"2015","journal-title":"BMC Cancer"},{"issue":"50","key":"10.1016\/j.humpath.2024.105703_bib38","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1038\/onc.2008.312","article-title":"Apoptotic signaling by c-MYC","volume":"27","author":"Hoffman","year":"2008","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.humpath.2024.105703_bib39","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2009-03-212670","article-title":"Suppression of B-cell lymphomagenesis by the BH3-only proteins bmf and bad","volume":"115","author":"Frenzel","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.humpath.2024.105703_bib40","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.humpath.2024.105703_bib41","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat Genet"},{"issue":"7418","key":"10.1016\/j.humpath.2024.105703_bib42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.humpath.2024.105703_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2012.06.012","article-title":"Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis","volume":"22","author":"Sander","year":"2012","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.humpath.2024.105703_bib44","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014282","article-title":"Oncogenic mechanisms in Burkitt lymphoma","volume":"4","author":"Schmitz","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"14","key":"10.1016\/j.humpath.2024.105703_bib45","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1182\/blood-2010-02-268003","article-title":"Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma","volume":"116","author":"Richter-Larrea","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105703_bib46","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18270","article-title":"MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs","volume":"5","author":"Wood","year":"2016","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.humpath.2024.105703_bib47","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V77.5.1092.1092","article-title":"Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma","volume":"77","author":"Neri","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105703_bib48","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22509","article-title":"Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection","volume":"6","author":"Price","year":"2017","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.humpath.2024.105703_bib49","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semcancer.2009.07.007","article-title":"How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?","volume":"19","author":"Allday","year":"2009","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"10.1016\/j.humpath.2024.105703_bib50","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1128\/jvi.64.9.4084-4092.1990","article-title":"Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes","volume":"64","author":"Sample","year":"1990","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.humpath.2024.105703_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02007-19","article-title":"Epstein-barr virus genomes reveal population structure and type 1 association with endemic Burkitt lymphoma","volume":"94","author":"Kaymaz","year":"2020","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105703_bib52","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/hemato3030030","article-title":"Burkitt lymphoma incidence in five continents","author":"Mbulaiteye","year":"2022","journal-title":"Hemato"},{"issue":"7","key":"10.1016\/j.humpath.2024.105703_bib53","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.24934","article-title":"Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005","volume":"126","author":"Mbulaiteye","year":"2010","journal-title":"Int J Cancer"},{"issue":"60","key":"10.1016\/j.humpath.2024.105703_bib54","first-page":"31","article-title":"Morphological definition of Burkitt's tumour: historical review and present status","author":"Berard","year":"1985","journal-title":"IARC Sci Publ"},{"issue":"10","key":"10.1016\/j.humpath.2024.105703_bib55","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","article-title":"Adult Burkitt leukemia and lymphoma","volume":"104","author":"Blum","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.humpath.2024.105703_bib56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000478-200403000-00011","article-title":"Florid granulomatous reaction in Epstein-Barr virus-positive nonendemic Burkitt lymphomas: report of four cases","volume":"28","author":"Haralambieva","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105703_bib57","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/his.14391","article-title":"Burkitt lymphoma with a granulomatous reaction: an M1\/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression","volume":"80","author":"Granai","year":"2022","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.humpath.2024.105703_bib58","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1111\/ijlh.13767","article-title":"Very rare Burkitt lymphoma with plasmacytoid differentiation, initial presentation as a CNS tumor, and poor prognosis","volume":"44","author":"Fuller","year":"2022","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105703_bib59","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.semdp.2017.04.003","article-title":"Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point","volume":"34","author":"Linke-Serins\u00f6z","year":"2017","journal-title":"Semin Diagn Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2024.105703_bib60","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2352-3026(20)30126-5","article-title":"HIV-associated Burkitt lymphoma","volume":"7","author":"Atallah-Yunes","year":"2020","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.humpath.2024.105703_bib61","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/cyto.b.21770","article-title":"Bright CD38 expression by flow cytometric analysis is a biomarker for double\/triple hit lymphomas with a moderate sensitivity and high specificity","volume":"96","author":"Alsuwaidan","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"10.1016\/j.humpath.2024.105703_bib62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/cyto.b.22157","article-title":"ROR1 expression in mature B lymphoid neoplasms by flow cytometry","volume":"106","author":"de Sousa","year":"2024","journal-title":"Cytometry B Clin Cytom"},{"issue":"10","key":"10.1016\/j.humpath.2024.105703_bib63","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2004-08-3112","article-title":"Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation","volume":"105","author":"Natkunam","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humpath.2024.105703_bib64","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/PAI.0000000000000107","article-title":"Diagnostic utility of the germinal center-associated markers GCET1, HGAL, and LMO2 in hematolymphoid neoplasms","volume":"23","author":"Menter","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105703_bib65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00428-015-1796-6","article-title":"Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas","volume":"467","author":"Kren\u00e1cs","year":"2015","journal-title":"Virchows Arch"},{"issue":"7","key":"10.1016\/j.humpath.2024.105703_bib66","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/PAS.0000000000000839","article-title":"LMO2-negative expression predicts the presence of MYC translocations in aggressive B-cell lymphomas","volume":"41","author":"Colomo","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105703_bib67","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13000-019-0876-3","article-title":"A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma","volume":"14","author":"Liu","year":"2019","journal-title":"Diagn Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105703_bib68","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/bjh.13624","article-title":"Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue","volume":"171","author":"Masqu\u00e9-Soler","year":"2015","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.humpath.2024.105703_bib69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1182\/blood.2023023242","article-title":"SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features","volume":"144","author":"Sureda-G\u00f3mez","year":"2024","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humpath.2024.105703_bib70","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ajpath.2012.12.013","article-title":"Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt's lymphoma","volume":"182","author":"Walther","year":"2013","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2024.105703_bib71","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.humpath.2008.07.021","article-title":"Frequent expression of multiple myeloma 1\/interferon regulatory factor 4 in Burkitt lymphoma","volume":"40","author":"Gualco","year":"2009","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2024.105703_bib72","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1182\/blood.V97.3.744","article-title":"Expression profile of MUM1\/IRF4, BCL-6, and CD138\/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas","volume":"97","author":"Carbone","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humpath.2024.105703_bib73","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1309\/EQJR3D3V0CCQGP04","article-title":"Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH","volume":"128","author":"Chuang","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2024.105703_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41408-019-0252-2","article-title":"Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases","volume":"9","author":"Mundo","year":"2019","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.humpath.2024.105703_bib75","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","article-title":"Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge","volume":"23","author":"Boerma","year":"2009","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.humpath.2024.105703_bib76","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.13501","article-title":"Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations","volume":"170","author":"Aukema","year":"2015","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.humpath.2024.105703_bib77","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cncr.22089","article-title":"Secondary chromosomal abnormalities predict outcome in pediatric and adult high-stage Burkitt lymphoma","volume":"107","author":"Onciu","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.humpath.2024.105703_bib78","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00277-020-03908-8","article-title":"In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes","volume":"99","author":"Opie","year":"2020","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.humpath.2024.105703_bib79","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/modpathol.2013.214","article-title":"Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP","volume":"27","author":"Tzankov","year":"2014","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105703_bib80","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.3324\/haematol.2018.207290","article-title":"False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms","volume":"104","author":"King","year":"2019","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.humpath.2024.105703_bib81","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/his.12178","article-title":"MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection","volume":"63","author":"Mu\u00f1oz-M\u00e1rmol","year":"2013","journal-title":"Histopathology"},{"issue":"15","key":"10.1016\/j.humpath.2024.105703_bib82","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood.2024025603","article-title":"Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2","volume":"144","author":"Collinge","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105703_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2022.12.001","article-title":"Clinical impact of 5(')MYC or 3(')MYC gain\/loss detected by FISH in patients with aggressive B-cell lymphomas","volume":"272\u2013273","author":"Tang","year":"2023","journal-title":"Cancer Genet"},{"issue":"7","key":"10.1016\/j.humpath.2024.105703_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100170","article-title":"Proteogenomic profiling of high-grade B-cell lymphoma with 11q aberrations and Burkitt lymphoma reveals lymphoid enhancer binding factor 1 as a novel biomarker","volume":"36","author":"Hurwitz","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105703_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2023.152182","article-title":"From the archives of MD Anderson Cancer Center: sporadic Burkitt lymphoma with a complex karyotype and SOX11 expression","volume":"66","author":"Siddiqui","year":"2023","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2024.105703_bib86","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1309\/AJCP0XQDGKFR0HTW","article-title":"A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma","volume":"133","author":"Schniederjan","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"23","key":"10.1016\/j.humpath.2024.105703_bib87","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.humpath.2024.105703_bib88","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41375-022-01778-9","article-title":"High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL\/HGBL-DH than DLBCL","volume":"37","author":"Li","year":"2023","journal-title":"Leukemia"},{"issue":"21","key":"10.1016\/j.humpath.2024.105703_bib89","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1182\/bloodadvances.2023009731","article-title":"High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study","volume":"7","author":"Zayac","year":"2023","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.humpath.2024.105703_bib90","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood.2020008374","article-title":"Defining and treating high-grade B-cell lymphoma, NOS","volume":"140","author":"Olszewski","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.humpath.2024.105703_bib91","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/modpathol.2017.186","article-title":"A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration","volume":"31","author":"Rymkiewicz","year":"2018","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2024.105703_bib92","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.MP.0000037310.82136.99","article-title":"Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features","volume":"15","author":"Hao","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105703_bib93","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-015-0163-z","article-title":"Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients","volume":"8","author":"Loghavi","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.humpath.2024.105703_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.155059","article-title":"Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan","volume":"253","author":"Chen","year":"2024","journal-title":"Pathol Res Pract"},{"issue":"9","key":"10.1016\/j.humpath.2024.105703_bib95","first-page":"790","article-title":"Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections","volume":"119","author":"Roth","year":"1995","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.humpath.2024.105703_bib96","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemia"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724002120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724002120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T16:41:44Z","timestamp":1741279304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817724002120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":96,"alternative-id":["S0046817724002120"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105703","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burkitt lymphoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105703"}}